BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Arthritis, Arthritis: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*other↝, *other↝, *CRP↓, *eff↝, *other↑, *CXCR4↓, *IL1β↓, *IL6↓, *IL17↓, *IL18↓, *TNF-α↓, *MMP9↓, *PGE2↓, *COX1↓, *COX2↓, *PI3K↓, *Akt↓, *other↑, TumCCA↑, Apoptosis↑, ROS↑, JNK↑, TumAuto↑, Hif1a↓, BNIP3↝, HSP90↓, Fas↑, FasL↑, ETC↓, VEGF↓, angioG↓, RadioS↑, *neuroP↑, *HSP70/HSPA5↑, *ROS↓, *MMP↑, *Cyt‑c↓, *Casp3↓, *Casp9↓, *MAPK↓, *Dose⇅, *HSPs↑, BioAv↓, Dose↝,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *hepatoP↑, *neuroP↑, *AntiCan↑, *toxicity↝, *BioAv↓, *HO-1↑, *NRF2↑, *NLRP3↑, *SOD↑, *SOD1↑, *ROS↓, *AntiAge↑, *ARE↑, *STAT↓, *NF-kB↓, *neuroG↑, *memory↑, ROS↑, NLRP3↑, CIP2A↓, Akt↓, STAT3↑, VEGFR2↓, DNMTs↓, MAPK↓, YAP/TEAD↓, PI3K↓, Wnt↓, NOTCH↓, TumCCA↑, TumCG↓, TumCP↓, FAK↑, MMP9↓, TumAuto↑, toxicity↝, BioAv↓, Half-Life↝, BioAv↑, selectivity∅,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*antiOx↑, *ROS↓, *angioG↓, *Inflam↓, *BioAv↓, *Half-Life↑, *GSH↑, *SOD↑, *Catalase↑, *Nrf1↑, *BP↓, *cardioP↑, *IL10↓, *TNF-α↓, *Aβ↓, *GSK‐3β↓, *tau↓, *neuroP↑, *Pain↓, *COX2↓, *NRF2↑, *HO-1↑, *IL1β↓, *IL17↓, *MCP1↓, PKCδ↓, ERK↓, BAX↓, cMyc↓, KRAS↓, ROS↓, selectivity↑, tumCV↓, Apoptosis↑, TumCCA↑, eff↑, P-gp↓, eff↑, eff↑, eff↑, eff↑, CycB/CCNB1↓, CDK1↓, CDK4↓, CDK2↓, TOP2↓, Cyt‑c↑, cl‑PARP↑, MMP↓, HSP70/HSPA5↓, HSP90↓, MDM2↓, RAS↓, eff↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
ETC↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, BAX↓, 1, Cyt‑c↑, 1, Fas↑, 1, FasL↑, 1, JNK↑, 1, MAPK↓, 1, MDM2↓, 1, YAP/TEAD↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↓, 1, HSP90↓, 2,
Autophagy & Lysosomes ⓘ
BNIP3↝, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNMTs↓, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, CDK2↓, 1, CDK4↓, 1, CycB/CCNB1↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
CIP2A↓, 1, ERK↓, 1, NOTCH↓, 1, PI3K↓, 1, RAS↓, 1, STAT3↑, 1, TOP2↓, 1, TumCG↓, 1, Wnt↓, 1,
Migration ⓘ
FAK↑, 1, KRAS↓, 1, MMP9↓, 1, PKCδ↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Protein Aggregation ⓘ
NLRP3↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 1, Dose↝, 1, eff↑, 6, Half-Life↝, 1, RadioS↑, 1, selectivity↑, 1, selectivity∅, 1,
Clinical Biomarkers ⓘ
KRAS↓, 1,
Functional Outcomes ⓘ
toxicity↝, 1,
Total Targets: 57
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, ARE↑, 1, Catalase↑, 1, GSH↑, 1, HO-1↑, 2, Nrf1↑, 1, NRF2↑, 2, ROS↓, 3, SOD↑, 2, SOD1↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Cell Death ⓘ
Akt↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other↑, 2, other↝, 2,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1, HSPs↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 1, neuroG↑, 1, PI3K↓, 1, STAT↓, 1,
Migration ⓘ
MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 2, CRP↓, 1, CXCR4↓, 1, IL10↓, 1, IL17↓, 2, IL18↓, 1, IL1β↓, 2, IL6↓, 1, Inflam↓, 2, MCP1↓, 1, NF-kB↓, 1, PGE2↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission ⓘ
tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1, NLRP3↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, Dose⇅, 1, eff↝, 1, Half-Life↑, 1,
Clinical Biomarkers ⓘ
BP↓, 1, CRP↓, 1, IL6↓, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiCan↑, 1, cardioP↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 3, Pain↓, 1, toxicity↝, 1,
Total Targets: 58
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:35 Cells:% prod#:% Target#:792 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page